Urteste (WSE:URTA) - Stock Price, News & Analysis

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

URTA Stock Overview

Engages in the research and development of diagnostic tests for cancers.

About the company

URTA fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Risk Analysis

Shares are highly illiquid

Has not reported any financial data

Does not have a meaningful market cap (PLN130M)

Urteste S.A. Competitors

Genomtec

WSE:GMT

zł151.4m

Poltreg

WSE:PTG

zł214.5m

Mabion

WSE:MAB

zł279.0m

Synthaverse

WSE:SVE

zł348.9m

Price History & Performance

Summary of all time highs, changes and price drops for Urteste
Historical stock prices
Current Share Price	zł114.00
52 Week High	zł118.00
52 Week Low	zł101.00
Beta	0
1 Month Change	3.64%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	3.64%

Recent updates

Shareholder Returns

	URTA	PL Biotechs	PL Market
7D	2.7%	1.7%	-2.4%
1Y	n/a	-17.7%	15.5%

Return vs Industry: Insufficient data to determine how URTA performed against the Polish Biotechs industry.

Return vs Market: Insufficient data to determine how URTA performed against the Polish Market.

Price Volatility

Is URTA's price volatile compared to industry and market?
URTA volatility
URTA Average Weekly Movement	n/a
Biotechs Industry Average Movement	5.7%
Market Average Movement	5.2%
10% most volatile stocks in PL Market	9.1%
10% least volatile stocks in PL Market	3.3%

Stable Share Price: URTA has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine URTA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2021	n/a	Grzegorz Stefanski	www.urteste.com

Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland.

Urteste S.A. Fundamentals Summary

How do Urteste's earnings and revenue compare to its market cap?
URTA fundamental statistics
Market cap	zł129.99m
Earnings (TTM)	zł0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is URTA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
URTA income statement (TTM)
Revenue	zł0
Cost of Revenue	zł0
Gross Profit	zł0
Other Expenses	zł0
Earnings	zł0

Last Reported Earnings

n/a

Next Earnings Date

Aug 11, 2023

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did URTA perform over the long term?

See historical performance and comparison

Urteste WSE:URTA Stock Report